Astellas adding 'off-the-shelf' stem cell tech in $102.5m acquisition
Astellas will bolster its regenerative medicine arm through the acquisition of pluripotent stem cell maker Universal Cells.
Read more: HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTICLE/2018/02/20/ASTELLAS-ADDING-OFF-THE-SHELF-STEM-CELL-TECH-IN-102.5M-ACQUISITION
Read more: HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTICLE/2018/02/20/ASTELLAS-ADDING-OFF-THE-SHELF-STEM-CELL-TECH-IN-102.5M-ACQUISITION